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Covid-19 mass testing: throwing the baby out with the bathwater?
Julian Peto, 1 David J Hunter, 2 Elio Riboli3
Abbasi1 and Gill2 rightly criticise the government’s
unevaluated coronavirus mass testing plan and the
appointment of commercial consultants and
contractors with little relevant expertise to design
and run it. The need is urgent, however, andTheBMJ
should campaign for Operation Moonshot to be
improved during rollout rather than stopped.3
Properly organised weekly testing would have been
evaluated in Southampton already if the local public
health team had been given the go ahead six months
ago.4 Funding for rapid rollout should include
generous furlough to make isolation attractive for
suspected contacts, particularly those who are poor,
togetherwith frequent retesting to allowearly release.
Efficientweekly screening requires a local population
register of names and contact details to issue
invitations, record results, and provide integrated
rapid access to household members and contacts. If
conducted by local public health authorities, which
know their communities best, this would greatly
improve the performance of test and trace
arrangements and might restore normal life many
months earlier than mass vaccination.5
Attacks on mass testing include the suggestion that
theHelsinkiDeclarationor dataprotection legislation
might be breached,6 which is as baseless and
irrelevant as the claim in a recent BMJ editorial that
PCR testing might miss 30% of coronavirus
infections.7 The apparently noble principle that
“nobody’s freedom or behaviour should be made
contingent on having had a novel rapid test”8
conflates a Trumpian trade-off between individual
liberty and public health with the incorrect
assumption that the false positive rate (0.6%, or
virtually zero with a confirmatory PCR test) is a major
problem with the lateral flow tests being used.
If this virus can be controlled by mass testing, the
next pandemic, which might involve a far more
dangerous new virus, could probably also be
suppressed until a vaccine could be developed and
distributed worldwide. Establishing the framework
for population testing in a few cities and evaluating
its impact on R during this epidemic should be
prioritised for that reason alone.
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